Uromedica, Inc. is a Minnesota-based medical device company that has developed long-term implantable balloon therapies for male and female stress urinary incontinence. Uromedica has safe and effective products that have been implanted in over 16,000 patients worldwide with excellent results. The balloons are implanted on either side of the bladder neck and do not require any patient manipulation. The implantation procedure takes approximately 30 minutes and the balloons are post-operatively adjustable through a subcutaneous port. The balloons may be easily removed during a safe and short office visit, if required, making Uromedica's devices truly minimally invasive. ProACT was FDA-approved for sale in the USA in November of 2015. ACT is not for sale in the USA. Uromedica will be commencing a clinical trial for ACT, the female application, in 2020.